心力衰竭的运动不耐受性与保存的喷射分数:原因,后果和朝着治愈的道路
Kanokwan Bunsawat1,2, Michael D Nelson3, Christopher M Hearon4
1Geriatric Research, Education, and Clinical Center, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
Experimental physiology
|December 8, 2023
概括
保持喷射分数 (HFpEF) 的心力衰竭是常见的,并且正在上升. 血管健康的下降有助于HFpEF,这表明干预措施可以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 生理学 生理学 生理学
- 血管生物学 血管生物学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭占心力衰竭病例的50%以上.
- 在全国范围内,HFpEF的流行率正在增加.
- 这种综合征涉及复杂的多器官功能障碍,需要采取综合性方法.
研究的目的:
- 在HFpEF中审查导致运动不耐受性的关键因素.
- 要突出心脏功能,动脉硬,血管功能和氧化代谢的作用.
- 讨论改善HFpEF结果的潜在治疗目标.
主要方法:
- 研讨会回顾当前的研究和临床演示.
- 对HFpEF的心脏,血管和代谢贡献的数据的整合.
- 分析影响HFpEF患者运动耐受性的因素.
主要成果:
- HFpEF的病理生理学包括心脏功能受损,动脉硬度增加和外周血管功能改变.
- 减少的氧气输送和利用显著影响HFpEF的运动能力.
- 有证据表明,血管健康的下降是HFpEF的一个关键特征.
结论:
- 血管健康受损是HFpEF的一个显著的,潜在的可修改的贡献者.
- 针对血管功能的药理和生活方式干预可以改善HFpEF结果.
- 对综合方法的进一步研究对于管理这种不断增长的患者群体至关重要.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Heart Failure Drugs: Diuretics
395
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
395
Pathophysiology of Cardiac Performance
672
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
672
Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341


